682 results on '"Sanz, Ferran"'
Search Results
202. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools
203. Correction: Automatic Filtering and Substantiation of Drug Safety Signals
204. A Chemocentric Approach to the Identification of Cancer Targets
205. Automatic Filtering and Substantiation of Drug Safety Signals
206. Inroads to Predict in Vivo Toxicology—An Introduction to the eTOX Project
207. Comparative analysis of putative agonist-binding modes in the human A1 adenosine
208. Formación en Informática Biomédica. Red INBIOMED
209. Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases
210. A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity
211. Induced Effects of Sodium Ions on Dopaminergic G-Protein Coupled Receptors
212. Synthesis, 3D‐QSAR, and Structural Modeling of Benzolactam Derivatives with Binding Affinity for the D2 and D3 Receptors
213. A Novel Multilevel Statistical Method for the Study of the Relationships between Multireceptorial Binding Affinity Profiles and In Vivo Endpoints
214. In silico prediction of in vivo toxicities (eTox)—The Innovative Medicines Initiative Approach
215. From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways
216. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
217. Synthesis, Binding Affinity, and Molecular Docking Analysis of New Benzofuranone Derivatives as Potential Antipsychotics
218. Corrigendum to “1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor” [Bioorg. Med. Chem. 16 (2008) 2852–2869]
219. Multi-Receptor Binding Profile of Clozapine and Olanzapine: A Structural Study Based on the New β2Adrenergic Receptor Template
220. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor
221. OSIRISv1.2: A named entity recognition system for sequence variants of genes in biomedical literature
222. IDENTIFYING GENE-SPECIFIC VARIATIONS IN BIOMEDICAL TEXT
223. Multistructure 3D-QSAR Studies on a Series of Conformationally Constrained Butyrophenones Docked into a New Homology Model of the 5-HT2A Receptor
224. Design, Synthesis, and Structure−Activity Relationships of 1-,3-,8-, and 9-Substituted-9-deazaxanthines at the Human A2B Adenosine Receptor
225. Anchor−GRIND: Filling the Gap between Standard 3D QSAR and the GRid-INdependent Descriptors
226. Validating SPONGIA, an expert system for sponge identification
227. Comparative Analysis of Putative Agonist-Binding Modes in the Human A1 Adenosine Receptor
228. Towards a MIP-based alignment and docking in computer-aided drug design
229. Incorporating Molecular Shape into the Alignment-free GRid-INdependent Descriptors
230. Sistemas informáticos de soporte a la decisión clínica
231. Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site
232. Preface
233. On the Generation of Catalytic Antibodies by Transition State Analogues
234. Comparison of biomolecules on the basis of Molecular Interaction Potentials
235. Influence of pH on the Binding of Diphenylmethylenepiperidines by 5-HT2B Receptors in Rat Stomach Fundus.
236. Service Oriented Architecture for Biomedical Collaborative Research.
237. A Structural Hierarchical Approach to Longitudinal Modeling of Effects of Air Pollution on Health Outcomes.
238. New Serotonin 5-HT2A, 5-HT2B, and 5-HT2C Receptor Antagonists: Synthesis, Pharmacology, 3D-QSAR, and Molecular Modeling of (Aminoalkyl)benzo and Heterocycloalkanones
239. An automated tool for obtaining QSAR-ready series of compounds using semantic web technologies.
240. Information technology in community pharmacies for supporting responsible self-medication
241. Conformationally Constrained Butyrophenones with Mixed Dopaminergic (D2) and Serotoninergic (5-HT2A, 5-HT2C) Affinities: Synthesis, Pharmacology, 3D-QSAR, and Molecular Modeling of (Aminoalkyl)benzo- and -thienocycloalkanones as Putative Atypical Antipsychotics.
242. Use of alignment-free molecular descriptors in diversity analysis and optimal sampling of molecular libraries
243. Validation of the Medical Expert System RENOIR
244. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes.
245. Applicability Domain Analysis (ADAN): A Robust Methodfor Assessing the Reliability of Drug Property Predictions.
246. Conformationally Constrained Butyrophenones with Mixed Dopaminergic (D2) and Serotoninergic (5-HT2A, 5-HT2C) Affinities: Synthesis, Pharmacology, 3D-QSAR, and Molecular Modeling of (Aminoalkyl)benzo- and -thienocycloalkanones as Putative Atypical Antipsychotics
247. Comparison of electrostatic similarity approaches applied to a series of ketanserin analogues with 5-HT2A antagonistic activity
248. Comparison of electrostatic similarity approaches applied to a series of ketanserin analogues with 5‐HT 2A antagonistic activity
249. Role of UEV-1, an Inactive Variant of the E2 UbiquitinConjugating Enzymes, in In Vitro Differentiation and Cell Cycle Behavior of HT-29-M6 Intestinal Mucosecretory Cells
250. Synthesis, Affinity at 5-HT2A, 5-HT2B and 5-HT2C Serotonin Receptors and Structure-Activity Relationships of a Series of Cyproheptadine Analogues.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.